in Newswire September 25, 2020

‘Wasteful’: Class Action Claims Genentech Reaped Millions by Selling Cancer, Asthma Drugs in Excessive Dosage Amounts

by Erin Shaak

Last Updated on September 25, 2020

Williamson et al. v. Genentech, Inc. et al.

Filed: September 24, 2020 § 3:20-cv-06695

A class action claims Genentech has sold medications in single-use vials that contain more medicine than is appropriate for most patients, causing excessive waste.

Last Updated on September 25, 2020 — 4:09 PM

Erin Shaak

Erin works primarily on’s newswire, reporting on cases as they happen.

About is a group of online professionals (designers, developers and writers) with years of experience in the legal industry.

Learn More

Before commenting, please review our comment policy.